The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) provides annual recommendations on the prevention, diagnosis and treatment of breast cancer. In the current update for axillary surgery, the presence of micrometastases and isolated tumor cells after Neoadjuvant Chemotherapy (NACT) and the clinical consequences of low volume axillary involvement assessed by SLNE and TAD were included for the first time. This article gives an overview of this year’s AGO recommendations for surgical management of the axilla in primary surgery of breast cancer and in the context of neoadjuvant treatment.
|Translated title of the contribution
|Surgical Treatment of Breast Cancer und oncological aspects. Axillary staging: when and how much is necessary?
|Number of pages
|Published - 2023
Research Areas and Centers
- Research Area: Luebeck Integrated Oncology Network (LION)
- Centers: University Cancer Center Schleswig-Holstein (UCCSH)
DFG Research Classification Scheme
- 205-14 Haematology, Oncology
- 205-21 Gynaecology and Obstetrics